116 related articles for article (PubMed ID: 1680871)
1. Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein.
Georges E; Zhang JT; Ling V
J Cell Physiol; 1991 Sep; 148(3):479-84. PubMed ID: 1680871
[TBL] [Abstract][Full Text] [Related]
2. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
Greenberger LM; Yang CP; Gindin E; Horwitz SB
J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
Yoshimura A; Kuwazuru Y; Sumizawa T; Ichikawa M; Ikeda S; Uda T; Akiyama S
J Biol Chem; 1989 Sep; 264(27):16282-91. PubMed ID: 2476441
[TBL] [Abstract][Full Text] [Related]
4. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.
Bruggemann EP; Germann UA; Gottesman MM; Pastan I
J Biol Chem; 1989 Sep; 264(26):15483-8. PubMed ID: 2475500
[TBL] [Abstract][Full Text] [Related]
5. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
Tamai I; Safa AR
J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
[TBL] [Abstract][Full Text] [Related]
6. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
[TBL] [Abstract][Full Text] [Related]
7. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
[TBL] [Abstract][Full Text] [Related]
9. ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.
Cornwell MM; Tsuruo T; Gottesman MM; Pastan I
FASEB J; 1987 Jul; 1(1):51-4. PubMed ID: 2886389
[TBL] [Abstract][Full Text] [Related]
10. Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.
Yang CP; Mellado W; Horwitz SB
Biochem Pharmacol; 1988 Apr; 37(7):1417-21. PubMed ID: 2895656
[No Abstract] [Full Text] [Related]
11. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.
Zordan-Nudo T; Ling V; Liu Z; Georges E
Cancer Res; 1993 Dec; 53(24):5994-6000. PubMed ID: 7903200
[TBL] [Abstract][Full Text] [Related]
12. [A molecular basis for multidrug resistance and reversal of the resistance].
Akiyama S; Yoshimura A; Kikuchi H; Kamiwatari M; Nagata Y; Seto K; Sakota R; Utsunomiya A; Hanada S; Hashimoto S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1266-72. PubMed ID: 2567148
[TBL] [Abstract][Full Text] [Related]
13. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
Greenberger LM
J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711
[TBL] [Abstract][Full Text] [Related]
14. Expression of human P-glycoprotein in yeast cells--effects of membrane component sterols on the activity of P-glycoprotein.
Saeki T; Shimabuku AM; Azuma Y; Shibano Y; Komano T; Ueda K
Agric Biol Chem; 1991 Jul; 55(7):1859-65. PubMed ID: 1369463
[TBL] [Abstract][Full Text] [Related]
15. Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells.
Poruchynsky MS; Ling V
Biochemistry; 1994 Apr; 33(14):4163-74. PubMed ID: 7908829
[TBL] [Abstract][Full Text] [Related]
16. Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.
Greenberger LM; Lisanti CJ; Silva JT; Horwitz SB
J Biol Chem; 1991 Nov; 266(31):20744-51. PubMed ID: 1682313
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
[TBL] [Abstract][Full Text] [Related]
18. Interaction of P-glycoprotein with a hydrophobic component of rat urine.
Charuk JH; Reithmeier RA
Biochem Biophys Res Commun; 1992 Jul; 186(2):796-802. PubMed ID: 1353959
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter.
Tanaka S; Currier SJ; Bruggemann EP; Ueda K; Germann UA; Pastan I; Gottesman MM
Biochem Biophys Res Commun; 1990 Jan; 166(1):180-6. PubMed ID: 1967936
[TBL] [Abstract][Full Text] [Related]
20. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
